fentanyl has been researched along with Carcinoma, Non-Small Cell Lung in 8 studies
Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In a male patient with non-small cell lung cancer who received palliative radiotherapy, the hyperpigmentation related to radiotherapy was examined two months later except for fentanyl transdermal patch area." | 7.83 | Can fentanyl transdermal patches prevent the cutaneous hyperpigmentation related to radiotherapy in patients with cancer? ( Mutlu, H, 2016) |
| " We treated a 50s female with pain and dyspnea from bone metastasis and lymphangitis carcinomatosa after surgery for NSCLC in whom the optimal dosages of transdermal fentanyl (Durotep Patch) were determined by titration with fentanyl injection, and oxycodone hydrochloride (OxyContin) in a short period." | 7.76 | [Successful management of a patient with pain and dyspnea from bone metastasis and lymphangitis carcinomatosa after surgery for non-small cell lung cancer (NSCLC) in whom optimal dosages of transdermal fentanyl were determined by titration with fentanyl i ( Eguchi, K; Gika, M; Inoue, Y; Izawa, N; Nakayama, M; Takeuchi, K, 2010) |
| " In a male patient with non-small cell lung cancer who received palliative radiotherapy, the hyperpigmentation related to radiotherapy was examined two months later except for fentanyl transdermal patch area." | 3.83 | Can fentanyl transdermal patches prevent the cutaneous hyperpigmentation related to radiotherapy in patients with cancer? ( Mutlu, H, 2016) |
| " We treated a 50s female with pain and dyspnea from bone metastasis and lymphangitis carcinomatosa after surgery for NSCLC in whom the optimal dosages of transdermal fentanyl (Durotep Patch) were determined by titration with fentanyl injection, and oxycodone hydrochloride (OxyContin) in a short period." | 3.76 | [Successful management of a patient with pain and dyspnea from bone metastasis and lymphangitis carcinomatosa after surgery for non-small cell lung cancer (NSCLC) in whom optimal dosages of transdermal fentanyl were determined by titration with fentanyl i ( Eguchi, K; Gika, M; Inoue, Y; Izawa, N; Nakayama, M; Takeuchi, K, 2010) |
| " The median intraoperative fentanyl equivalents dosage was 10." | 1.40 | A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection. ( Cata, JP; Engle, M; Feng, L; Gottumukkala, V; Keerty, D; Keerty, V; Mehran, JR; Norman, PH, 2014) |
| "Additionally, gabapentin was given for neuropathic pain uncontrolled by opioids." | 1.37 | [Oxycodone and pregabalin using transdermal fentanyl patch provided relief of symptoms for postherpetic neuropathic pain in a patient with non-small cell lung cancer]. ( Ando, A; Nishimura, D; Shibahara, H; Suzuki, S; Uematsu, N, 2011) |
| " In addition, the total daily dose of ketorolac was reduced following a change from intermittent bolus dosing to a continuous infusion." | 1.30 | Prolonged central intravenous ketorolac continuous infusion in a cancer patient with intractable bone pain. ( Gordon, RL, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cata, JP | 3 |
| Bauer, M | 1 |
| Sokari, T | 1 |
| Ramirez, MF | 1 |
| Mason, D | 1 |
| Plautz, G | 1 |
| Kurz, A | 1 |
| Gottumukkala, V | 2 |
| Thakar, D | 1 |
| Keerty, D | 2 |
| Gebhardt, R | 1 |
| Liu, DD | 1 |
| Keerty, V | 1 |
| Feng, L | 1 |
| Norman, PH | 1 |
| Mehran, JR | 1 |
| Engle, M | 1 |
| Mutlu, H | 1 |
| Gika, M | 1 |
| Eguchi, K | 1 |
| Inoue, Y | 1 |
| Izawa, N | 1 |
| Takeuchi, K | 1 |
| Nakayama, M | 1 |
| Shibahara, H | 1 |
| Ando, A | 1 |
| Suzuki, S | 1 |
| Uematsu, N | 1 |
| Nishimura, D | 1 |
| Juba, KM | 1 |
| Wahler, RG | 1 |
| Daron, SM | 1 |
| Gordon, RL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Anesthetic Technique on Natural Killer Cell Population and Cytotoxicity[NCT02669186] | 20 participants (Anticipated) | Interventional | 2019-07-10 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 other studies available for fentanyl and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Effects of surgery, general anesthesia, and perioperative epidural analgesia on the immune function of patients with non-small cell lung cancer.
Topics: Aged; Analgesia, Epidural; Analgesics, Opioid; Anesthesia, General; Carcinoma, Non-Small-Cell Lung; | 2013 |
Effects of postoperative epidural analgesia on recurrence-free and overall survival in patients with nonsmall cell lung cancer.
Topics: Age Factors; Aged; Amides; Analgesia, Epidural; Analgesia, Patient-Controlled; Analgesics, Opioid; A | 2014 |
A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection.
Topics: Analgesics, Opioid; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Dose-Response Relationshi | 2014 |
Can fentanyl transdermal patches prevent the cutaneous hyperpigmentation related to radiotherapy in patients with cancer?
Topics: Analgesics, Opioid; Carcinoma, Non-Small-Cell Lung; Fentanyl; Humans; Hyperpigmentation; Lung Neopla | 2016 |
[Successful management of a patient with pain and dyspnea from bone metastasis and lymphangitis carcinomatosa after surgery for non-small cell lung cancer (NSCLC) in whom optimal dosages of transdermal fentanyl were determined by titration with fentanyl i
Topics: Administration, Cutaneous; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Dyspnea; Female; Fentanyl | 2010 |
[Oxycodone and pregabalin using transdermal fentanyl patch provided relief of symptoms for postherpetic neuropathic pain in a patient with non-small cell lung cancer].
Topics: Aged; Analgesics, Opioid; Carcinoma, Non-Small-Cell Lung; Fentanyl; gamma-Aminobutyric Acid; Humans; | 2011 |
Morphine and hydromorphone-induced hyperalgesia in a hospice patient.
Topics: Adult; Analgesics, Opioid; Carcinoma, Non-Small-Cell Lung; Delayed-Action Preparations; Female; Fent | 2013 |
Prolonged central intravenous ketorolac continuous infusion in a cancer patient with intractable bone pain.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Cathet | 1998 |